US 9266813
Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof
granted A61PA61P35/00A61P43/00
Quick answer
US patent 9266813 (Stilbenoid compound as inhibitor for squamous carcinoma and hepatoma and uses thereof) held by China Medical University expires Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- China Medical University
- Grant date
- Tue Feb 23 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Feb 18 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P43/00